A new blood test could detect lung cancer recurrence months before it appears on scans, potentially enabling earlier ...

New findings suggest that a blood test can detect circulating tumor DNA (ctDNA), potentially identifying signs of lung cancer ...

Abbott’s next-gen Oncodetect molecular residual disease (MRD) test detects traces of circulating tumor DNA in a patient’s ...

A revolutionary blood test designed to detect more than 50 types of cancer has failed to achieve its main goal in a trial ...

For many people with cancer, completing treatment can bring a new uncertainty: Is my cancer really gone? Even after treatment, small amounts of cancer may remain in the body at levels that can be ...

Learn about a new blood test that could lead to earlier detection and treatment of breast cancer.

The updates improve upon the option for a first-line screening tool for those who are unable or unwilling to receive the more ...

A new blood test could diagnose pancreatic cancer much earlier, improving survival rates for people with the disease. A large part of the reason for this poor prognosis is that pancreatic cancer is ...

Despite advances in early-stage lung cancer treatment, a significant number of patients experience disease recurrence after ...

Want to B-positive about your health? Johns Hopkins researchers have developed a cutting-edge blood test that can detect signs of cancer three years before any symptoms surface. The breakthrough could ...

Researchers at USC have launched an early-stage clinical trial to investigate whether a blood test could help detect breast ...